Covidien has completed enrolling the first patient in SWIFT PRIME trial of its Solitaire FR Revascularisation device, designed to restore blood flow, administer medical therapy as well as retrieve clot in patients with acute ischemic ...
Tags: Covidien, patient, SWIFT PRIME trial
ElectroCore has initiated enrolling patients in a clinical trial of its GammaCore nVNS therapy, designed for preventing chronic migraine. The easy-to-use, non-invasive device, which enables self-administration of therapy, stimulates ...
Medtronic has completed enrolling the first patient in MIRACLE EF clinical trial, designed to evaluate the effectiveness of its Consulta cardiac resynchronization therapy-pacemaker (CRT-P) in treating symptomatic heart failure patients with ...
Tags: Medtronic, MIRACLE EF, trial, CRT-P
CardioKinetix has completed enrolling the first patient in PARACHUTE IV trial of its Parachute ventricular partitioning device for treating heart failure patients. The minimally invasive device is deployed into the left ventricle to ...
SinuSys has received regulatory approvals from Health Canada and Australian Therapeutic Goods Administration (TGA) for its AerOs sinus dilation system, designed for the treatment of chronic sinusitis. Designed for use in office-based ...
Tags: SinuSys, Health Canada, Australian Therapeutic Goods Administration
Biosensors International Group has completed enrolling the first patient in its polymer-free drug-coated stent's (DCS) clinical trial, designed to compare the safety of the BioFreedom with a bare-metal stent (BMS). Designed for use in ...
Sunshine Heart has obtained a conditional approval from the US Food and Drug Administration (FDA) for its investigational device exemption (IDE)) implantable heart assist device. The non-blood contacting C-Pulse Heart Assist device, ...
Tags: C-Pulse IDE Device, FDA, clinical trial
pSivida has completed enrolling first US patient in investigator-sponsored clinical trial of its injectable sustained release insert. pSivida president and CEO Ashton said the trial will study the use of injectable micro-inserts to treat ...
Tags: pSivida, clinical trial, injectable sustained release insert
EndoGastric Solutions announced that patient enrollment has been completed for its Transoral Incisionless Fundoplication (TIF) versus Medical Proton Pump Inhibitor (PPI) Management of Refractory GERD symptoms (TEMPO) trial. The ...
Tags: EndoGastric, patient enrollment, TIF, TIF procedure trial, TEMPO trial
Boston Scientific has completed enrolling first patient in REPRISE II clinical trial, designed to assess the safety and efficacy of the Lotus Valve system in minimizing aortic regurgitation (leaking). The Lotus Valve system, which the ...
Tags: Boston Scientific, first patient, REPRISE II clinical trial
Medtronic has completed enrolling patients in a clinical trial of its Amphirion drug-eluting balloon, designed to treat critical limb ischemia. The CE-marked Amphirion drug-eluting balloon features proprietary FreePac proprietary ...
Tags: Medtronic, clinical trial, limb ischemia, Amphirion drug-eluting balloon
CardioKinetix has started enrolling patients for its PARACHUTE III, a post-market safety surveillance trial, in Germany. The dual-arm, multi-center, open-label trial, which will enroll up to 100 ischemic heart failure patients, is ...
Vascular Nanotransfer Technologies has reported in vivo test results of its paclitaxel nanocarrier-based Drug Coated Balloon (DCB) technology, designed for patients with coronary in-stent restenosis and peripheral vascular disease. ...
Tags: Drug Coated Balloon, medical technology, clinical trial
Endosense, a provider of cardiac technologies, has completed enrolling patients in its Toccastar clinical study. The prospective, randomized, multi-center investigational device exemption trial, which enrolled 300 patients with ...
Tags: Endosense, Toccastar clinical study, cardiac technologies
Boston Scientific, a provider of cardiovascular implants, has completed enrolling patients in its Prevail confirmatory study. The CE-marked self-expanding nitinol frame Watchman device, placed in the left atrial appendage (LAA) via the ...
Tags: Boston Scientific, cardiovascular implants, Prevail confirmatory study